SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Korea
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

SEOULIN BIO SCIENCE CO.,LTD.

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
SEOULIN BIO SCIENCE CO.,LTD.

Headquarters
4TH FL.,A-DONG,KOREA BIO PARK,694-1, SAMPYEONG-DONG, BUNDANG-GU, SEONGNAM-SI, GYEONGGI-DO; Seongnam; Gyeonggi; 134848
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Financial Auditors: DAEJOO (2011)
Incorporation Date: April 1, 1994
Total Employees: 87

Tel: 02-1670-5911

Company Description

Sales increased on robust sales of DNA chip-related equipment and diagnostic reagents. Its net profit fell on decreased non-operating income, but its operating income increased. The company has a nationwide sales network with 12 offices, and the number of daily visitors to the offices reached 1,000. Sales are forecast to increase as the company plans to release a new diagnostic reagent and other products. Its status in the bio-related industry is expected to strengthen on a series of new diagnostic
More

Company Analysis

According to the Individual - Audited financial statement for the first half of 2012, total net operating revenues increased with 38.15%, from KRW 19,461,937 thousands to KRW 26,886,112 thousands. Operating result increased from KRW 1,942,903 thousands to KRW 3,073,259 thousands which means 58.18% change. The results of the period increased 46.16% reaching KRW 2,538,572 thousands at the end of the period against KRW 1,736,818 thousands last year. Return on equity (Net income/Total equity) went from 5.94% to 7.74%, the Return On Asset (Net income / Total Asset) went from 3.68% to 5.08% and the Net Profit Margin (Net Income/Net Sales) went from 8.92% to 9.44% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 52.25% compared to 61.43% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.49 to 3.30 when compared to the previous year.

Key Executives

Hwang,Eul Mun President
Jeon,Ung Non-Executive Independent Director
Oh,Jae Ki Auditor
An,Jong Cheol Senior Managing Director
Choe,Geol Yong Senior Managing Director
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

56,628,312

49,947,323

Current Assets

37,600,340

31,426,808

Total Liabilities

19,325,220

17,142,250

Shareholders Equity

37,303,091

32,805,073

Current Liabilities

12,237,214

9,533,105

* All the accounts are in KRW.
Income Statement

Total Operating Revenue

53,393,607

26,886,112

Operational Profit (Loss)

5,549,752

3,073,259

Net Profit (Loss)

4,809,270

2,538,572

* All the accounts are in KRW.
Ratios
Profitability Ratios

Return on Assets (ROA)

8.49%

5.08%

Return on Equity (ROE)

12.89%

7.74%

Return on Sales (ROS)

9.01%

9.44%

Return on Capital

10.83%

6.28%

Gross Profit Margin

33.61%

33.3%

Efficiency Ratios

Current asset turnover

1.42x

0.86x

Asset Turnover

0.94x

0.54x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

3,524,424

1,994,693

EBITDA

5,800,563

3,187,652

Bookvalue (BV)

36,487,612

31,998,543

Liquidity Ratios

Current Ratio

307.26%

329.66%

Quick ratio

273.67%

291.18%

Doom's day ratio

16.03%

48.18%

Cash Flow to Debt

-3.27%

11.71%

Leverage Ratios

Leverage ratio

151.81%

152.25%

Interest Coverage Ratio

2,065.65%

2,018.06%

Debt to equity

51.81%

52.25%

Debt to total assets

34.13%

34.32%

Long Term Debt to Capital

15.97%

18.83%

Market ratios

Price/Book Ratio

1.28

0.86

Trend Ratios

Revenue Trend

135.3%

138.15%

Net Income Trend

146.05%

146.16%